Mage Biologics announces first subject dosed in a Phase 1 trial with MB-001, an orally administered antibody for Inflammatory Bowel Disease
June 12, 2024
June 12, 2024
June 11, 2024
June 5, 2024
May 15, 2024
May 15, 2024
May 15, 2024
May 14, 2024
May 2, 2024
April 22, 2024
October 30, 2025
Lonza to acquire Redberry SAS, an innovative company specializing in rapid microbiology testing solutions Acquisition to include Red One™ solid-phase ...
October 29, 2025
Collaboration aims to deliver rapid, lab-quality testing to communities worldwide – making precision health more accessible EazeBio today announced a ...
October 9, 2025
Alithea Genomics, a leader in next-generation transcriptomic solutions, today announced the commercial launch of MERCURIUS™ Spheroid DRUG-seq, a novel...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225